A certificate of analysis is useful only when it connects a named material to a specific batch and then reports what was tested, the rule used to judge it and the result obtained. A polished PDF with a logo and a single “purity” number does not accomplish that job.
The most useful regulatory reference is ICH Q7, section 11.4. It describes a COA as batch-specific and identifies the information that should make the record traceable: material name and grade, batch number, release date, retest or expiry date, tests performed, acceptance limits, numerical results when applicable, and dated authorization by the quality unit. For a repacked or reprocessed material, the original manufacturer should also remain traceable.
The first check: does the document identify the lot?
Start with the material name, form and lot number. A peptide name alone can be ambiguous: acetate, trifluoroacetate or another counterion may change formula weight and content calculations; a terminal modification may change mass; a blend requires component-level identification. The catalog number on the web page, the label and the COA should form one traceable chain.
A generic “typical analysis” can describe a method or historical range, but it is not a batch COA. If the same certificate is served for every lot, or the batch field is absent, the document cannot establish what was released for the material being considered.
Read every row as test, method, limit and result
| Field | Question to ask | Common weak version |
|---|---|---|
| Test | What quality attribute was measured? | “Purity” without defining chromatographic, chemical or mass basis |
| Method | Which validated or qualified procedure generated the result? | “HPLC” without method or specification reference |
| Acceptance limit | What pass/fail rule applied at release? | “Conforms” with no visible criterion |
| Result | What did this batch actually produce? | Repeating the specification instead of a numerical result |
| Status and date | Who authorized release, and when? | An undated signature graphic or automated stamp |
“Conforms” can be legitimate for an attribute that is qualitative, but it hides too much when a quantitative method generated a number. Q7 specifically calls for numerical results where applicable. A separate chromatogram or spectrum can provide important context, but it must still be tied to the same sample and batch.
One purity result is not a complete specification
Reversed-phase HPLC area percentage describes the relative detector response of resolved peaks under a stated method. It does not automatically measure peptide mass fraction in the vial. Identity evidence, water, counterions, residual solvents, inorganic residue, bioburden or endotoxin may require different procedures. Which tests are appropriate depends on material, intended laboratory work and specification.
Likewise, a mass-spectrometry match supports identity at the level the method can resolve. An intact mass alone may not distinguish every isomer, sequence permutation or modification. The correct question is not “Does the COA show MS?” but “What identity claim does this method and result actually support?”
Check dates without inventing shelf life
The release date records the quality decision. A retest date says when the material should be re-examined under the defined program; an expiry date marks a claimed period of conformance. Neither date should be inferred from a standard freezer label. It needs a documented stability basis for the material, container-closure system and storage condition.
A certificate copied from an earlier batch cannot establish the current batch’s release status. Ask whether the displayed document is a specimen, a lot-specific record available on request or the actual record for the selected lot.
A practical review sequence
- Match name, exact form, catalog identifier and lot across the label, quote and COA.
- Confirm the issuer and, where applicable, original manufacturer remain traceable.
- For each critical attribute, locate the test, method reference, acceptance limit and actual result.
- Open supporting chromatograms or spectra and confirm they carry the same sample or batch identity.
- Separate HPLC area purity, identity and quantitative content; do not let one substitute for another.
- Check release authorization, date and the documented basis for retest, expiry and storage statements.
What a COA cannot prove by itself
A COA is a controlled summary, not independent verification. It does not show raw data, audit trails, instrument qualification, method validation or the complete manufacturing history. It also cannot establish safety or efficacy. For higher-risk or high-value work, the right next step may be a fuller data package, supplier qualification or independent confirmatory testing.
The disciplined conclusion is deliberately narrow: a complete, internally consistent COA supports a batch-release claim within its listed methods and limits. It should never be converted into a broader claim about biological performance, clinical suitability or results that were not tested.
Sources & editorial method
The editorial workflow starts with linked regulatory guidance and peer-reviewed analytical-method records; extracts scope, definitions, required fields and limitations; and separates general method principles from product- and lot-specific claims. AI-assisted drafting was used to structure the first version. Claims, examples and boundaries were checked against the linked records in the site editorial workflow. This is not independent peer review or evidence that any catalog lot has passed the tests described.
3 linked records are listed in the references below. Read the editorial and AI-assistance policy.
How to interpret this article
This guide explains document structure. It is not a COA, does not verify a supplier or batch, and does not imply that any catalog lot meets the example checks.
Research-use boundary: Catalog materials discussed on this website are for laboratory research, development and manufacturing use only, not for human or veterinary use. This content is not medical advice and does not provide administration instructions.
Primary records and authoritative sources
- ICH Q7: Good Manufacturing Practice Guidance for Active Pharmaceutical IngredientsSection 11.4 lists batch-specific certificate-of-analysis fields and quality-unit approval expectations.
- ICH Q2(R2): Validation of Analytical ProceduresDefines validation characteristics and distinguishes quantitative analytical purposes.
- FDA: Questions and Answers on CGMP Requirements—Laboratory ControlsOfficial FDA explanations of laboratory methods, controls and data expectations.
Continue the documentation review
Each guide answers a different analytical question. Use the complete set before treating one number as a complete quality record.
Open the complete Quality & Documentation Hub
